# Trazodone in Painful Diabetic Neuropathy

> **NCT03202979** · PHASE2 · COMPLETED · sponsor: **Aziende Chimiche Riunite Angelini Francesco S.p.A** · enrollment: 142 (actual)

## Conditions studied

- Painful Diabetic Neuropathy

## Interventions

- **DRUG:** Trazodone 20 mg
- **DRUG:** Trazodone 10 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03202979
- **Lead sponsor:** Aziende Chimiche Riunite Angelini Francesco S.p.A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-16
- **Primary completion:** 2018-08-09
- **Final completion:** 2018-08-09
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2018-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03202979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03202979, "Trazodone in Painful Diabetic Neuropathy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03202979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*